The first global scientific assessment of endocrine-disrupting chemicals in 14 years concludes that exposure begins before birth, with these substances detected in umbilical cord blood and breast milk. The 240-page report by the UN Environment Programme and the World Health Organization finds the evidence for harm to fertility, brain development, thyroid function, metabolism, immunity and cardiovascular health stronger than in 2012. Its central criticism of regulators is procedural: people are exposed to mixtures, while most systems still assess one chemical at a time. More than 350,000 chemicals and mixtures are in registered use, and only a small fraction has been assessed for endocrine effects.
Hormones work at vanishingly small concentrations, and they work by timing. A signal that is useful at one stage of development can be harmful at another. That is the reason endocrine-disrupting chemicals, or EDCs, occupy an awkward place in chemical regulation: substances that look harmless by the usual measures of acute toxicity may still interfere with the hormonal signals that shape a developing body.
On Monday, UNEP and WHO published State of the Science of Endocrine-Disrupting Chemicals 2026, requested by the UN Environment Assembly. It is the first major update since 2012, with earlier assessments in 2002 and 2012, and it was launched at the first International Conference of the Global Framework on Chemicals in Geneva, which runs until 20 November.
What the report finds
The report’s headline conclusion is about timing. Exposure can begin before birth: EDCs have been detected in blood, in breast milk and in umbilical cord blood, and early-life exposure can have lasting effects on brain development, growth and reproductive health.
Compared with 2012, the agencies say the evidence has strengthened for effects on fertility and reproductive development; brain development and neurological function; the regulation of thyroid and other hormones; metabolism; immunity; and cardiovascular health. Metabolic liver disease is identified as an emerging concern, along with possible effects on the kidneys, and the report acknowledges that significant gaps remain in both areas.
The chemicals named in the agencies’ joint release are bisphenol A, phthalates and polychlorinated biphenyls. Exposure routes include plastics in food packaging, toys and medical devices, pesticides and personal-care products, reaching people by ingestion, through the skin, by inhalation and through medical equipment. Agency reporting of the launch adds links to cancer, obesity, type 2 diabetes and cardiovascular disease, and describes current policies as “fragmented and insufficient”.
The report also covers wildlife, where impaired reproduction, development and behaviour have been documented in fish, birds, amphibians and mammals.
Two numbers frame the regulatory problem. More than 350,000 chemicals and mixtures are registered for use worldwide, and only a small fraction has been assessed for endocrine effects. The cost of disease linked to EDCs is put at 1% or more of global GDP, which agency reporting translates to more than US$1.1 trillion a year, a figure the report itself describes as conservative because it excludes water contamination, biodiversity and effects on food production.
Mixtures, and the whack-a-mole problem
The report’s sharpest criticism is methodological. Real exposure is to mixtures, often at low concentrations, and many regulatory systems still assess chemicals individually. A set of substances each judged safe on its own may not be safe in combination, and the report urges that mixtures be assessed as such.
A related difficulty is substitution. Where a chemical is restricted, manufacturers may replace it with a structurally similar compound that has not been studied. Laura Vandenberg of the University of Massachusetts Amherst, a lead author, described replacing bisphenol A with close analogues as a “whack-a-mole problem”, and said there is now “irrefutable evidence linking EDCs to human health effects”. Her challenge to policymakers was direct: “in many, many cases we know enough to act. Why haven’t we acted?”
The agencies are, however, careful to record that regulation has worked where it has been tried: harm from older, legacy EDCs has been reversed where regulators reduced contamination.
“What makes EDCs particularly concerning is that they can disrupt hormones that regulate many essential functions,” said Sheila Aggarwal Khan, director of UNEP’s Industry and Economy Division. “These effects can be long-lasting and, in some cases, irreversible.” She also framed the business case: “The businesses that test early, disclose what is in their products, and get substitution right will be ahead of regulation.”
Bruce Gordon, acting director of WHO’s department of environment, climate change, One Health and migration, put the public-health principle plainly: “Protecting health means preventing harmful exposures before they occur.” The industry view, voiced by the American Chemistry Council, is that safe use is paramount and that existing regulatory frameworks are the right vehicle.
The recommendations are to phase out the most problematic chemicals, promote safer alternatives, assess mixtures, strengthen monitoring, protect pregnant women and children, and act across the food packaging, cosmetics, toy, textile, healthcare, agriculture, pharmaceutical and waste sectors. A companion synthesis document, From Evidence to Action, addresses implementation.
Where India stands
India’s regulatory position on the substances the report highlights is partly settled and partly still in draft.
Bisphenol A. The Bureau of Indian Standards specification for plastic feeding bottles, IS 14625:2015, has barred BPA since 2015. Independent testing has found the restriction imperfectly observed: a 2019 study by Toxics Link, conducted at IIT Guwahati, reported that all 20 feeding bottles and sippy cups it tested leached BPA at 0.9 to 10.5 parts per billion, including some labelled “BPA-free”. Those are seven-year-old data and NSH has not seen a more recent equivalent survey.
Food-contact materials. The Food Safety and Standards Authority of India has drafted an amendment to its packaging regulations that would prohibit PFAS in food-contact materials and require polycarbonate and epoxy food-contact materials to be free of BPA and its derivatives. The draft was notified to the World Trade Organization in December 2025, with comments closing in February 2026. NSH found no evidence that it has been finalised, and treats it as a draft.
Phthalates in toys. The BIS toy-safety standard IS 9873 (Part 3) limits several phthalates in mouthable parts of toys for children under four to 0.1% or less, and the Toys (Quality Control) Order of 2020 makes BIS certification mandatory.
PFAS more broadly. India has no national PFAS-specific limits for products or drinking water. It ratified the Stockholm Convention in 2006 but has not ratified the listings for PFOS, PFOA or PFHxS, and the draft Chemical Management Rules of 2020, which name PFOS and PFOA, have not been notified. A single civil-society source indicates that rules on contaminated sites adopted in 2025 restrict some of these substances in groundwater; NSH could not corroborate that and does not rely on it.
Limitations
NSH read the agencies’ joint release and the publication record, not the full 240-page report. PFAS is not named in the joint release, and the specific findings on PFAS within the report body were not verified. Health associations of the kind the report describes are drawn from epidemiology and animal studies; the report itself is explicit about remaining gaps, particularly on the liver and kidneys.
– Sai Chaitanya Puligadda



